BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24451804)

  • 1. Hedgehog Pathway in Pediatric Cancers: They're Not Just for Brain Tumors Anymore.
    Macdonald TJ
    Am Soc Clin Oncol Educ Book; 2012; ():605-9. PubMed ID: 24451804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened.
    Pietrobono S; Gagliardi S; Stecca B
    Front Genet; 2019; 10():556. PubMed ID: 31244888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells.
    Miele E; Po A; Begalli F; Antonucci L; Mastronuzzi A; Marras CE; Carai A; Cucchi D; Abballe L; Besharat ZM; Catanzaro G; Infante P; Di Marcotullio L; Canettieri G; De Smaele E; Screpanti I; Locatelli F; Ferretti E
    BMC Cancer; 2017 Jul; 17(1):488. PubMed ID: 28716052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the Hedgehog signaling pathway in cancer: A comprehensive review.
    Skoda AM; Simovic D; Karin V; Kardum V; Vranic S; Serman L
    Bosn J Basic Med Sci; 2018 Feb; 18(1):8-20. PubMed ID: 29274272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
    Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
    J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance.
    Palle K; Mani C; Tripathi K; Athar M
    Cancers (Basel); 2015 Nov; 7(4):2330-51. PubMed ID: 26633513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers.
    Li QR; Zhao H; Zhang XS; Lang H; Yu K
    Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Bad Is the Hedgehog? GLI-Dependent, Hedgehog-Independent Cancers on the Importance of Biomarkers for Proper Patients Selection.
    Javelaud D; De Reyniès A; Mauviel A
    J Investig Dermatol Symp Proc; 2018 Dec; 19(2):S87-S88. PubMed ID: 30471761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response.
    Gambini D; Passoni E; Nazzaro G; Beltramini G; Tomasello G; Ghidini M; Kuhn E; Garrone O
    Front Med (Lausanne); 2022; 9():893063. PubMed ID: 35775005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule modulators of the Sonic Hedgehog signaling pathway.
    Stanton BZ; Peng LF
    Mol Biosyst; 2010 Jan; 6(1):44-54. PubMed ID: 20024066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of hedgehog pathway inhibitors by epigenetically targeting GLI through BET bromodomain for the treatment of medulloblastoma.
    Liu X; Zhang Y; Li Y; Wang J; Ding H; Huang W; Ding C; Liu H; Tan W; Zhang A
    Acta Pharm Sin B; 2021 Feb; 11(2):488-504. PubMed ID: 33643826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors.
    Pietrobono S; Stecca B
    Cells; 2018 Dec; 7(12):. PubMed ID: 30558232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Smoothened-Dependent and -Independent Hedgehog Signaling Pathway in Tumorigenesis.
    Chai JY; Sugumar V; Alshawsh MA; Wong WF; Arya A; Chong PP; Looi CY
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma.
    Lim CB; Prêle CM; Cheah HM; Cheng YY; Klebe S; Reid G; Watkins DN; Baltic S; Thompson PJ; Mutsaers SE
    PLoS One; 2013; 8(6):e66685. PubMed ID: 23826113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors.
    Rimkus TK; Carpenter RL; Qasem S; Chan M; Lo HW
    Cancers (Basel); 2016 Feb; 8(2):. PubMed ID: 26891329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-4, a Well-Tolerated and Orally Active Inhibitor of Hedgehog Pathway, Exhibited Potent Anti-tumor Effects Against Medulloblastoma
    Zhu M; Wang H; Wang C; Fang Y; Zhu T; Zhao W; Dong X; Zhang X
    Front Pharmacol; 2019; 10():89. PubMed ID: 30846937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?
    Eibenschutz L; Caputo S; Camera E; Carbone A; Silipo V; Migliano E; Aurizi C; Cota C; Frascione P; Bellei B
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gorlin syndrome (nevoid basal cell carcinoma syndrome): update and literature review.
    Fujii K; Miyashita T
    Pediatr Int; 2014 Oct; 56(5):667-74. PubMed ID: 25131638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Response of
    Geyer N; Ridzewski R; Bauer J; Kuzyakova M; Dittmann K; Dullin C; Rosenberger A; Schildhaus HU; Uhmann A; Fulda S; Hahn H
    Front Oncol; 2018; 8():396. PubMed ID: 30319965
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.